Factors Associated with Rivaroxaban Prescribing in Specialist Care Setting: Interim Results from the Rivaroxaban Observational Safety Evaluation (ROSE) Study

被引：0
|
作者：
Layton, Deborah [1 ,2 ]
Evans, Alison [1 ,2 ]
Davies, Miranda [1 ,2 ]
Osborne, Vicki [1 ,2 ]
Shakir, Saad A. W. [1 ,2 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmoth, Portsmouth, Hants, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
337
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [31] Investigation of pain associated with endotracheal aspiration and affecting factors in an intensive care setting: A prospective observational study
    Ozsaban, Aysel
    Cura, Sengul Uzen
    Coskun, Ela Yilmaz
    Kibar, Dilanur
    AUSTRALIAN CRITICAL CARE, 2023, 36 (05) : 687 - 694
  • [32] Evaluating Prescriber Concordance with Prescribing: Results from a Post-Marketing Study in Primary Care Setting
    Layton, D.
    Qayum, N.
    Due, C.
    Freemantle, S.
    Shakir, S.
    DRUG SAFETY, 2015, 38 (10) : 940 - 940
  • [33] Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert
    Najafzadeh, Mehdi
    Bessette, Lily G.
    Zakoul, Heidi
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES, 2021, 70
  • [34] Effectiveness and safety of empagliflozin in routine care patients: interim results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Bessette, L.
    Franklin, J.
    Najafzadeh, M.
    Wexler, D.
    Deruaz-Luyet, A.
    Brodovicz, K.
    Schneeweiss, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S145 - S146
  • [35] Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Franklin, Jessica
    Najafzadeh, Mehdi
    Wexler, Deborah J.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Schneeweiss, Sebastian
    DIABETES, 2020, 69
  • [36] EVENTS ASSOCIATED WITH NEXPLANON INSERTION AND REMOVAL: INTERIM RESULTS FROM THE NEXPLANON OBSERVATIONAL RISK ASSESSMENT STUDY (NORA)
    Reed, S.
    Heinemann, K.
    CONTRACEPTION, 2016, 94 (04) : 409 - 409
  • [37] PATTERNS OF TOCILIZUMAB USE AND SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS: INTERIM RESULTS FROM A MULTINATIONAL OBSERVATIONAL STUDY (ENCORE PRESENTATION)
    Haraoui, B.
    Casado, G.
    Theander, E.
    Czirjak, L.
    Taylor, A.
    Button, P.
    Gylvin, Hinsch L.
    Caporali, R.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 28 - 28
  • [38] REGIONAL PATTERNS OF TOCILIZUMAB USE, EFFICACY, AND SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS: INTERIM RESULTS FROM A MULTINATIONAL OBSERVATIONAL STUDY
    Haraoui, B.
    Casado, G.
    Theander, E.
    Czirjak, L.
    Taylor, A.
    Mikes, E.
    Reiss, W.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1042 - 1043
  • [39] Patient factors associated with initiation of behavioral weight loss treatment: a prospective observational study in an integrated care setting
    McVay, Megan A.
    Yancy, William S., Jr.
    Scott, Christine N.
    Wilson-Barlow, Lindsay
    Woolson, Sandra
    McSherry, W. Clint
    Allen, Sandra
    Voils, Corrine I.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2017, 7 (01) : 75 - 83
  • [40] Efficacy and safety data of the treatment with azacitidine in a routine care setting in germany; data from the first planned Interim analysis of the non-interventional study "Observational study on treatment patterns VIDAZA®"
    Platzbecker, U.
    Lueck, A.
    Prange-Krex, G.
    Lollert, A.
    Schwarzer, A.
    Schwinger, U.
    Uhlig, J.
    Bachinger, A.
    Weiligmann, C.
    Steudel, C.
    Illmer, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 252 - 252
12345